Medipal Holdings Corp.

  • Market Cap: Mid Cap
  • Industry: Retailing
  • ISIN: JP3268950007
JPY
2,625.50
13 (0.5%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationQuarterly Results
Results Snapshot
YoYQoQ
Figures in Million
Consolidate Quarterly Results
Mar'26
Dec'25
Sep'25
Jun'25
Mar'25
Dec'24
Sep'24
Net Sales
9,05,687.00
10,14,105.00
9,52,403.00
9,45,159.00
8,64,156.00
9,82,500.00
9,15,355.00
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
9,05,687.00
10,14,105.00
9,52,403.00
9,45,159.00
8,64,156.00
9,82,500.00
9,15,355.00
Raw Material Cost
8,47,172.00
9,48,769.00
8,90,171.00
8,83,834.00
8,06,025.00
9,18,095.00
8,54,897.00
Purchase of Finished goods
0.00
0.00
0.00
0.00
0.00
0.00
0.00
(Increase) / Decrease In Stocks
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Employee Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
4.00
3.00
3.00
3.00
2.00
2.00
2.00
Selling and Distribution Expenses
48,516.00
47,234.00
51,203.00
47,271.00
47,893.00
46,195.00
46,580.00
Other Expenses
-0.40
-0.30
-0.30
-0.30
-0.20
-0.20
-0.20
Total Expenditure (Excl Depreciation)
8,95,688.00
9,96,003.00
9,41,374.00
9,31,105.00
8,53,918.00
9,64,290.00
9,01,477.00
Operating Profit (PBDIT) excl Other Income
9999
18102
11029
14054
10238
18210
13878
Other Income
15,667.00
8,944.00
14,042.00
5,064.00
794.00
7,651.00
8,712.00
Operating Profit (PBDIT)
39,956.00
31,747.00
29,691.00
23,700.00
15,678.00
30,486.00
27,244.00
Interest
4.00
3.00
3.00
3.00
2.00
2.00
2.00
Exceptional Items
-10,396.00
-275.00
-3,922.00
-450.00
-236.00
311.00
-183.00
Gross Profit (PBDT)
58,515.00
65,336.00
62,232.00
61,325.00
58,131.00
64,405.00
60,458.00
Depreciation
14,290.00
4,701.00
4,620.00
4,582.00
4,646.00
4,625.00
4,654.00
Profit Before Tax
15,266.00
26,769.00
21,143.00
18,666.00
10,791.00
26,169.00
22,407.00
Tax
7,931.00
8,448.00
6,271.00
6,053.00
4,488.00
8,511.00
6,845.00
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
5,120.00
15,324.00
12,504.00
9,587.00
4,042.00
14,511.00
12,718.00
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
5,120.00
15,324.00
12,504.00
9,587.00
4,042.00
14,511.00
12,718.00
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
2,215.00
2,997.00
2,369.00
3,025.00
2,261.00
3,147.00
2,844.00
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
7,335.00
18,321.00
14,873.00
12,612.00
6,303.00
17,658.00
15,562.00
Equity Capital
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Face Value
0.0
0.0
0.0
0.0
0.0
0.0
0.0
Reserves
6,52,174.00
6,41,207.00
6,23,681.00
6,16,581.00
6,19,566.00
6,25,995.00
6,18,442.00
Earnings per share (EPS)
25.01
74.68
60.63
46.17
19.43
69.78
60.99
Diluted Earnings per share
25.01
74.68
60.63
46.17
19.43
69.78
60.99
Operating Profit Margin (Excl OI)
1.1%
1.79%
1.16%
1.49%
1.18%
1.85%
1.52%
Gross Profit Margin
3.26%
3.1%
2.71%
2.46%
1.79%
3.13%
2.96%
PAT Margin
0.57%
1.51%
1.31%
1.01%
0.47%
1.48%
1.39%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Quarterly Analysis Highlights - YoY
stock-summary

Net Sales

YoY Growth in quarter ended Mar 2026 is 4.81% vs 2.41% in Mar 2025

stock-summary

Consolidate Net Profit

YoY Growth in quarter ended Mar 2026 is 16.37% vs -58.07% in Mar 2025

stock-summary

Operating Profit (PBDIT) excl Other Income

YoY Growth in quarter ended Mar 2026 is 63.19% vs 1.29% in Mar 2025

stock-summary

Interest

YoY Growth in quarter ended Mar 2026 is 100.00% vs 0.00% in Mar 2025

stock-summary

Operating Profit Margin (Excl OI)

YoY Growth in quarter ended Mar 2026 has fallen from Mar 2025

Compare Quarterly Results Of Medipal Holdings Corp. With
Markets Mojo
Figures in Million
Consolidate Quarterly Results
Markets Mojo
Markets Mojo
Change(JPY)
Change(%)
Net Sales
9,05,687.00
7,40,978.00
1,64,709.00
22.23%
Other Operating Income
0.00
0.00
0.00
Total Operating income
9,05,687.00
7,40,978.00
1,64,709.00
22.23%
Raw Material Cost
8,47,172.00
6,88,227.00
1,58,945.00
23.09%
Purchase of Finished goods
0
0
0.00
(Increase) / Decrease In Stocks
0
0
0.00
Employee Cost
0.00
0.00
0.00
Power Cost
0
0
0.00
Manufacturing Expenses
4.00
94.00
-90.00
-95.74%
Selling and Distribution Expenses
48,516.00
46,318.00
2,198.00
4.75%
Other Expenses
-0.40
-9.40
9.00
95.74%
Total Expenditure (Excl Depreciation)
8,95,688.00
7,34,545.00
1,61,143.00
21.94%
Operating Profit (PBDIT) excl Other Income
9,999.00
6,433.00
3,566.00
55.43%
Other Income
15,667.00
9,420.00
6,247.00
66.32%
Operating Profit (PBDIT)
39,956.00
19,912.00
20,044.00
100.66%
Interest
4.00
94.00
-90.00
-95.74%
Exceptional Items
-10,396.00
-1,056.00
-9,340.00
-884.47%
Gross Profit (PBDT)
58,515.00
52,751.00
5,764.00
10.93%
Depreciation
14,290.00
4,059.00
10,231.00
252.06%
Profit Before Tax
15,266.00
14,705.00
561.00
3.82%
Tax
7,931.00
4,964.00
2,967.00
59.77%
Provisions and contingencies
0
0
0.00
Profit After Tax
5,120.00
9,765.00
-4,645.00
-47.57%
Extraordinary Items
0.00
0.00
0.00
Prior Period Expenses
0
0
0.00
Other Adjustments
0
0
0.00
Net Profit
5,120.00
9,765.00
-4,645.00
-47.57%
Share in Profit of Associates
0
0
0.00
Minority Interest
2,215.00
-25.00
2,240.00
8,960.00%
Other related items
0.00
0.00
0.00
Consolidated Net Profit
7,335.00
9,740.00
-2,405.00
-24.69%
Equity Capital
0
0
0.00
Face Value
0.00
0.00
0.00
Reserves
6,52,174.00
5,07,358.00
1,44,816.00
28.54%
Earnings per share (EPS)
25.01
53.74
-28.73
-53.46%
Diluted Earnings per share
25.01
53.74
-28.73
-53.46%
Operating Profit Margin (Excl OI)
1.10%
0.87%
0.00
0.23%
Gross Profit Margin
3.26%
2.53%
0.00
0.73%
PAT Margin
0.57%
1.32%
0.00
-0.75%
Public Share Holdings (%)
0%
0%
0.00
0.00%
Pledged Promotor Holding (%)
0%
0%
0.00
0.00%
Quarterly - Net Sales
Net Sales 90,568.70 Million
in Mar 2026

Figures in Million
stock-summary

QoQ Growth in quarter ended Mar 2026 is -10.69% vs 6.48% in Dec 2025

stock-summary

YoY Growth in quarter ended Mar 2026 is 4.81% vs 2.41% in Mar 2025

Quarterly - Consolidate Net Profit
Consolidate Net Profit 733.50 Million
in Mar 2026

Figures in Million
stock-summary

QoQ Growth in quarter ended Mar 2026 is -59.96% vs 23.18% in Dec 2025

stock-summary

YoY Growth in quarter ended Mar 2026 is 16.37% vs -58.07% in Mar 2025

Quarterly - Operating Profit (PBDIT)
Operating Profit (PBDIT) 2,428.90 Million
in Mar 2026

Figures in Million
stock-summary

QoQ Growth in quarter ended Mar 2026 is 6.52% vs 45.72% in Dec 2025

stock-summary

YoY Growth in quarter ended Mar 2026 is 63.19% vs 1.29% in Mar 2025

Quarterly - Interest
Interest 0.40 Million
in Mar 2026

Figures in Million
stock-summary

QoQ Growth in quarter ended Mar 2026 is 33.33% vs 0.00% in Dec 2025

stock-summary

YoY Growth in quarter ended Mar 2026 is 100.00% vs 0.00% in Mar 2025

Quarterly - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 1.10%
in Mar 2026

Figures in %
stock-summary

QoQ Growth in quarter ended Mar 2026 has fallen from Dec 2025

stock-summary

YoY Growth in quarter ended Mar 2026 has fallen from Mar 2025